Cargando…
Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
The recent spread of Zika virus (ZIKV) in the Americas and Asia necessitates an increased preparedness for improved maternal and perinatal health and blood safety. However, serological cross-reactions, especially to Dengue virus (DENV), complicate ZIKV antibody serodiagnosis. A novel “pan-Flavi” sus...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599479/ https://www.ncbi.nlm.nih.gov/pubmed/28852878 http://dx.doi.org/10.1007/s00430-017-0517-y |
_version_ | 1783264065776254976 |
---|---|
author | Rönnberg, Bengt Gustafsson, Åke Vapalahti, Olli Emmerich, Petra Lundkvist, Åke Schmidt-Chanasit, Jonas Blomberg, Jonas |
author_facet | Rönnberg, Bengt Gustafsson, Åke Vapalahti, Olli Emmerich, Petra Lundkvist, Åke Schmidt-Chanasit, Jonas Blomberg, Jonas |
author_sort | Rönnberg, Bengt |
collection | PubMed |
description | The recent spread of Zika virus (ZIKV) in the Americas and Asia necessitates an increased preparedness for improved maternal and perinatal health and blood safety. However, serological cross-reactions, especially to Dengue virus (DENV), complicate ZIKV antibody serodiagnosis. A novel “pan-Flavi” suspension multiplex immunoassay (PFSMIA) using 25 antigens, whole virus (WV), non-structural protein 1 (NS1), and envelope (E) proteins, from 7 zoonotic flaviviruses for specific detection of ZIKV and DENV IgM and IgG was developed. Patterns of antibody cross-reactivity, avidity, and kinetics were established in 104 sera from returning travelers with known ZIKV and DENV infections. PFSMIA gave IgM- and IgG-sensitivities for both viruses of 96–100%, compared to an immunofluorescence assay. Main IgM cross-reactions were to NS1, for IgG to the E and WV antigens. Infecting virus yielded reactivity to several antigens of the homologous virus, while cross-reactions tended to occur only to a single antigen from heterologous virus(es). A specificity-enhancing computer procedure took into account antibody isotype, number of antibody-reactive antigens per virus, avidity, average degree of cross-reactivity to heterologous flavivirus antigens, and reactivity changes in serial sera. It classified all 50 cases correctly. Applied to sera from 200 pregnant women and 173 blood donors from Sweden, one blood donor was found ZIKV NS1 IgM positive, and another as ZIKV NS1 IgG positive. These samples did not react with other ZIKV antigens and were thereby judged as false-positives. PFSMIA provided sensitive and specific ZIKV and DENV serology, warranting high-throughput serological surveillance and a minimized need for laborious and expensive virus neutralization assays. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00430-017-0517-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5599479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-55994792017-10-03 Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections Rönnberg, Bengt Gustafsson, Åke Vapalahti, Olli Emmerich, Petra Lundkvist, Åke Schmidt-Chanasit, Jonas Blomberg, Jonas Med Microbiol Immunol Original Investigation The recent spread of Zika virus (ZIKV) in the Americas and Asia necessitates an increased preparedness for improved maternal and perinatal health and blood safety. However, serological cross-reactions, especially to Dengue virus (DENV), complicate ZIKV antibody serodiagnosis. A novel “pan-Flavi” suspension multiplex immunoassay (PFSMIA) using 25 antigens, whole virus (WV), non-structural protein 1 (NS1), and envelope (E) proteins, from 7 zoonotic flaviviruses for specific detection of ZIKV and DENV IgM and IgG was developed. Patterns of antibody cross-reactivity, avidity, and kinetics were established in 104 sera from returning travelers with known ZIKV and DENV infections. PFSMIA gave IgM- and IgG-sensitivities for both viruses of 96–100%, compared to an immunofluorescence assay. Main IgM cross-reactions were to NS1, for IgG to the E and WV antigens. Infecting virus yielded reactivity to several antigens of the homologous virus, while cross-reactions tended to occur only to a single antigen from heterologous virus(es). A specificity-enhancing computer procedure took into account antibody isotype, number of antibody-reactive antigens per virus, avidity, average degree of cross-reactivity to heterologous flavivirus antigens, and reactivity changes in serial sera. It classified all 50 cases correctly. Applied to sera from 200 pregnant women and 173 blood donors from Sweden, one blood donor was found ZIKV NS1 IgM positive, and another as ZIKV NS1 IgG positive. These samples did not react with other ZIKV antigens and were thereby judged as false-positives. PFSMIA provided sensitive and specific ZIKV and DENV serology, warranting high-throughput serological surveillance and a minimized need for laborious and expensive virus neutralization assays. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00430-017-0517-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-08-29 2017 /pmc/articles/PMC5599479/ /pubmed/28852878 http://dx.doi.org/10.1007/s00430-017-0517-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Investigation Rönnberg, Bengt Gustafsson, Åke Vapalahti, Olli Emmerich, Petra Lundkvist, Åke Schmidt-Chanasit, Jonas Blomberg, Jonas Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections |
title | Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections |
title_full | Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections |
title_fullStr | Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections |
title_full_unstemmed | Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections |
title_short | Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections |
title_sort | compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of zika versus other flavivirus infections |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599479/ https://www.ncbi.nlm.nih.gov/pubmed/28852878 http://dx.doi.org/10.1007/s00430-017-0517-y |
work_keys_str_mv | AT ronnbergbengt compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections AT gustafssonake compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections AT vapalahtiolli compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections AT emmerichpetra compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections AT lundkvistake compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections AT schmidtchanasitjonas compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections AT blombergjonas compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections |